V-Bio Management 2: what changed
V-Bio Management 2
Largest movements
- Receivables within one year -€198,183
down €198,183 (-37.2%), from €532,400 to €334,217
- Cash +€20,071
up €20,071 (+36.1%), from €55,648 to €75,719
mainly Accrued charges and deferred income (+€340,633) and Receivables within one year (+€198,183)
- Trade debts -€522,455
down €522,455 (-99.1%), from €527,372 to €4,917
- Accrued charges and deferred income +€340,633
new in 2025: €340,633
- Turnover +€66,151
up €66,151 (+3.1%), from €2.1m to €2.2m
- Purchases and services +€64,913
up €64,913 (+3.1%), from €2.1m to €2.2m
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €588,048 | €409,936 | -€178,112 | -30.3% |
| Current assets | 29/58 | €588,048 | €409,936 | -€178,112 | -30.3% |
| Amounts receivable within one year | 40/41 | €532,400 | €334,217 | -€198,183 | -37.2% |
| Trade receivables | 40 | €532,400 | €334,217 | -€198,183 | -37.2% |
| Cash at bank and in hand | 54/58 | €55,648 | €75,719 | +€20,071 | +36.1% |
| Total equity and liabilities | 10/49 | €588,048 | €409,936 | -€178,112 | -30.3% |
| Equity | 10/15 | €59,871 | €63,528 | +€3,657 | +6.1% |
| Contributions | 10/11 | €50,001 | €50,001 | = | 0.0% |
| Reserves | 13 | €9,870 | €13,527 | +€3,657 | +37.1% |
| Distributable reserves | 133 | €9,870 | €13,527 | +€3,657 | +37.1% |
| Amounts payable | 17/49 | €528,177 | €346,408 | -€181,769 | -34.4% |
| Amounts payable within one year | 42/48 | €528,177 | €5,775 | -€522,402 | -98.9% |
| Trade debts | 44 | €527,372 | €4,917 | -€522,455 | -99.1% |
| Suppliers | 440/4 | €527,372 | €4,917 | -€522,455 | -99.1% |
| Taxes, remuneration and social security | 45 | €805 | €858 | +€53 | +6.6% |
| Taxes | 450/3 | €805 | €858 | +€53 | +6.6% |
| Accrued charges and deferred income | 492/3 | - | €340,633 | +€340,633 | |
| Turnover | 70 | €2,129,600 | €2,195,751 | +€66,151 | +3.1% |
| Goods, raw materials, services and sundry goods | 60/61 | €2,123,906 | €2,188,819 | +€64,913 | +3.1% |
| Other operating charges | 640/8 | €2,423 | €2,499 | +€76 | +3.1% |
| Gross operating margin | 9900 | €5,694 | €6,932 | +€1,238 | +21.7% |
| Operating profit (loss) | 9901 | €3,271 | €4,433 | +€1,162 | +35.5% |
| Financial charges | 65/66B | €52 | €53 | +€1 | +1.9% |
| Recurring financial charges | 65 | €52 | €53 | +€1 | +1.9% |
| Non-recurring financial charges | 66B | €52 | €53 | +€1 | +1.9% |
| Profit (loss) for the period before taxes | 9903 | €3,219 | €4,380 | +€1,161 | +36.1% |
| Income taxes | 67/77 | €316 | €723 | +€407 | +129% |
| Profit (loss) for the period | 9904 | €2,903 | €3,657 | +€754 | +26.0% |
| Profit (loss) for the period to be appropriated | 9905 | €2,903 | €3,657 | +€754 | +26.0% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.